Marko Skelin
Impact in
-
- Thyroid Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Diabetes Treatment and Management
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
-
- Metabolism, Diabetes, and Cancer 2
- Kruppel-like factors research 2
- Co-authors
- Tomo Lucijanić (7 shared papers)Dario Rahelić (7 shared papers)Marko Lucijanić (11 shared papers)Daniela Amidžić Klarić (1 shared paper)Hossein Gharib (1 shared paper)Vlatko Pejša (2 shared papers)Rajko Kušec (2 shared papers)Tajana Štoos‐Veić (2 shared papers)
- Journals
- International Journal of Clinical Practice (2 papers)European Archives of Oto-Rhino-Laryngology (2 papers)Biomedicines (1 paper)Reviews in Cardiovascular Medicine (1 paper)Anticancer Research (1 paper)
- Partner nations
- CroatiaUnited StatesIreland
In The Last Decade
Marko Skelin
23 papers receiving 277 citations
Peers
Comparison fields: 5 of 63
- Endocrinology, Diabetes and Metabolism 81
- Genetics 52
- Otorhinolaryngology 17
- Hematology 25
- Internal Medicine 6
Countries citing papers authored by Marko Skelin
This map shows the geographic impact of Marko Skelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Skelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Skelin more than expected).
Fields of papers citing papers by Marko Skelin
This network shows the impact of papers produced by Marko Skelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Skelin. The network helps show where Marko Skelin may publish in the future.
Co-authors
The 25 scholars most cited alongside Marko Skelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 88 | |
| 2 | 2018 | 32 | |
| 3 | 2018 | 29 | |
| 4 | 2019 | 21 | |
| 5 | 2018 | 21 | |
| 6 | 2017 | 20 | |
| 7 | 2016 | 19 | |
| 8 | 2019 | 11 | |
| 9 | 2023 | 7 | |
| 10 | 2021 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 6 | |
| 13 | 2018 | 6 | |
| 14 | 2022 | 2 | |
| 15 | 2020 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2018 | 1 |
About Marko Skelin
Marko Skelin is a scholar working on Genetics, Molecular Biology, Endocrinology, Diabetes and Metabolism, Otorhinolaryngology and Hematology, having authored 26 papers that have together received 284 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Head and Neck Cancer Studies (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Diabetes Treatment and Management (2 papers), Kruppel-like factors research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Vitamin C and Antioxidants Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (81 citations), Genetics (52 citations), Otorhinolaryngology (17 citations), Hematology (25 citations) and Internal Medicine (6 citations). Marko Skelin has collaborated with scholars based in Croatia, United States and Ireland. Frequent co-authors include Tomo Lucijanić, Dario Rahelić, Marko Lucijanić, Daniela Amidžić Klarić, Hossein Gharib, Vlatko Pejša, Rajko Kušec, Tajana Štoos‐Veić, Ivica Lukšić and Ivan Krečak. Their work appears in journals such as International Journal of Clinical Practice, European Archives of Oto-Rhino-Laryngology, Biomedicines, Reviews in Cardiovascular Medicine and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.